COVID-19 Policies & Procedures
Powers drafted the attached template COVID-19 Policies and Procedures that incorporate HRSA/OPA’s relaxed guidance to help 340B covered entities address the coronavirus pandemic. We hope that you find these Policies…
Fighting to Preserve the Benefits of the 340B Program
Powers drafted the attached template COVID-19 Policies and Procedures that incorporate HRSA/OPA’s relaxed guidance to help 340B covered entities address the coronavirus pandemic. We hope that you find these Policies…
On April 2, the Food and Drug Administration (FDA) announced that, effective immediately, it is modifying its current policy to shorten the abstinence period, from 12 months to 3 months,…